Through the program, the company will introduce seven new manufacturing sites that will be completed and operational by the end of 2020.
Saint-Gobain Life Sciences announced the launch of its EUR 70-million (US$77-million) global expansion program on Nov. 21, 2019. Through the program, the company will introduce seven new manufacturing sites that will be completed and operational by the end of 2020.
According to a company press release, the program was kicked off with the construction of the company’s Bangalore, India, site in September of 2019, and, recently, the company ended construction on its Largo, FL, facility for the production of its C-Flex tubing, molded connections, and assemblies. The additional facilities will be located in Beaverton, MI; Charny, France; Dublin, Ireland; Hangzhou, China; and Songdo, South Korea.
“This is an exciting time in our business,” said Jean Angus, CEO, Saint-Gobain Life Sciences, in the press release. “This is the execution of a multi-year plan to expand our global manufacturing footprint, which will enhance our ability to service our Life Sciences customers globally with redundant manufacturing facilities. We are increasing the regional availability of our products and our ability to meet customers’ growing demands.”
Source: Saint-Gobain Life Sciences
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.